ArticleJournal of comparative effectiveness research2026
Indirect comparisons of tucatinib in combination with trastuzumab for patients with previously treated HER2-positive metastatic colorectal cancer.
Claire Watkins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.